Andere talen Taysha Gene Therapies, Inc.

Aandelen

TSHA

US8776191061

Vertraagde tijd Nasdaq Andere beurzen 21:51:35 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,455 ^USD	+0,20%		-2,96%	+38,70%

09/04	TAYSHA GENE THERAPIES, INC. : Piper Sandler ontvangt een koopadvies	ZM
21/03	TAYSHA GENE THERAPIES, INC. : Chardan Research handhaaft koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	05/04
Wall Street Set to Open Flat as Investors Look Toward Fed Decision; Oil Prices Drop Sharply	20/03
US Futures Flat in Wednesday's Premarket as Investors Await Fed's Interest Rate Decision	20/03
Top Premarket Gainers	20/03
Taysha Gene Therapies Surges 26% Premarket After Full-Year 2023 Results Show Narrowing Net Loss, Surging Revenue	20/03
North American Morning Briefing : Markets on Hold as Fed Decision Nears	20/03
Taysha Gene Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates	19/03
Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19	14/03
Taysha Gene Therapies : March 2024 Corporate Presentation	08/03
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	01/03
Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome	29/02
Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs	15/02
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	02/02
Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference	22/01
Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome	10/01
Taysha Gene Therapies, Inc. Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome	10/01
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	05/01
Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene Therapies	19/12
Taysha Gene Therapies, Inc.(NasdaqGS:TSHA) added to NASDAQ Biotechnology Index	18/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Taysha Gene Therapies, Inc.

Aandelen

TSHA

US8776191061

Andere talen

Filters